AKT1 and rheumatoid arthritis: The results indicated that the CFCG plays a role in treating RA at least partially via reducing the activities of the PI3K-Akt signaling pathway, MAPK signaling pathway, TNF signaling pathway, and NF-κB signaling pathway.